View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
November 14, 2011

Baxter International acquires Baxa

Baxter International has acquired Baxa, the US-based developer of pharmacy technology, for a cash consideration of $380m.

Baxter International has acquired Baxa, the US-based developer of pharmacy technology, for a cash consideration of $380m.

Baxter Medical Products develops, manufactures and markets products used in the delivery of fluids and drugs to patients.

Baxter Medical Products business president Robert Davis said the transaction will allow Baxter to provide a broader range of solutions for the safe preparation and delivery of IV medications.

"We believe Baxa’s expertise in safely preparing IV and oral liquid medications, and their shared commitment toward improving patient care through innovative drug preparation and delivery technology, will benefit patients around the world," Davis added.

Baxter’s product portfolio includes ExactaMix, ExactaMed syringes, NeoThrive enteral feeding system, enteral syringes and accessories and the DoseEdge pharmacy workflow manager for managing IV and oral dose preparation activities.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology